BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 24819660)

  • 1. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ; Joseph NT; Berkowitz RS; Goldstein DP
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center.
    Gockley AA; Joseph NT; Melamed A; Sun SY; Goodwin B; Bernstein M; Goldstein DP; Berkowitz RS; Horowitz NS
    Am J Obstet Gynecol; 2016 Sep; 215(3):334.e1-6. PubMed ID: 27130239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M; Mirzamoradi M; Kimyaiee P; Aghaie A; Mansournia MA; Ashrafi-Vand S; Sarfjoo FS
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A; Biscaro A; do Amaral Giordani JM; Viggiano M; Elias KM; Berkowitz RS; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gestational trophoblastic neoplasia after human chorionic gonadotropin normalization in a retrospective cohort of 7761 patients in France.
    Descargues P; Hajri T; Massardier J; Lotz JP; Devouassoux-Shisheboran M; Allias Montmayeur F; You B; Golfier F; Bolze PA
    Am J Obstet Gynecol; 2021 Oct; 225(4):401.e1-401.e9. PubMed ID: 34019886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear regression of postevacuation serum human chorionic gonadotropin concentrations predicts postmolar gestational trophoblastic neoplasia.
    Lybol C; Sweep FC; Ottevanger PB; Massuger LF; Thomas CM
    Int J Gynecol Cancer; 2013 Jul; 23(6):1150-6. PubMed ID: 23714707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?
    Dantas PRS; Maestá I; Filho JR; Junior JA; Elias KM; Howoritz N; Braga A; Berkowitz RS
    Gynecol Oncol; 2017 Nov; 147(2):364-370. PubMed ID: 28927899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of laparoscopic surgery in the diagnosis of suspected gestational trophoblastic neoplasia cases with uterine mass].
    Li X; Feng F; Xiang Y; Wan X; Ren T; Yang J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):910-4. PubMed ID: 26887874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
    J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we need post-pregnancy screening with human chorionic gonadotrophin after previous hydatidiform mole to identify patients with recurrent gestational trophoblastic disease?
    Earp KE; Hancock BW; Short D; Harvey RA; Fisher RA; Drew D; Sarwar N; Tidy JA; Winter MC; Chien P; Seckl MJ
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():117-119. PubMed ID: 30684876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation, medical complications and development of gestational trophoblastic neoplasia of hydatidiform mole after intracytoplasmic sperm injection as compared to hydatidiform mole after spontaneous conception - a retrospective cohort study and literature review.
    Braga A; Andrade T; do Carmo Borges de Souza M; Campos V; Freitas F; Maestá I; Sun SY; Pedrotti LG; Bessel M; Junior JA; Filho JR; Elias KM; Horowitz NS; Berkowitz RS
    Gynecol Oncol; 2023 Mar; 170():179-185. PubMed ID: 36706644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of previous cesarean section (C/S) on the risk for post-molar gestational trophoblastic neoplasia (GTN).
    Cho HW; Ouh YT; Min KJ; Lee NW; Lee S; Song JY; Hong JH; Lee JK
    Gynecol Oncol; 2020 Mar; 156(3):606-610. PubMed ID: 31954533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A; Maestá I; Short D; Savage P; Harvey R; Seckl MJ
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.